Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Transcriptomic and Proteomic Analyses Reveal the Potential Mode of Action of Chondrocyte Sheets in Hyaline Cartilage Regeneration.

Toyoda E, Sato M, Takahashi T, Maehara M, Okada E, Wasai S, Watanabe M, Iijima H, Nonaka K, Kawaguchi Y.

Int J Mol Sci. 2019 Dec 24;21(1). pii: E149. doi: 10.3390/ijms21010149.

2.

A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients.

Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y, Nakamura Y, Hashida K, Honda G, Fukuzawa K, Toyoda E, Tanabe M, Gotohda N, Matsumoto I, Ryu T, Uyama I, Kojima T, Unno M, Ichikawa D, Inoue Y, Matsukawa H, Sudo T, Takaori K, Yamaue H, Eguchi S, Tahara M, Shinzeki M, Eguchi H, Kurata M, Morimoto M, Hayashi H, Marubashi S, Inomata M, Kimura K, Amaya K, Sho M, Yoshida R, Murata A, Yoshitomi H, Hakamada K, Yasunaga M, Abe N, Hioki M, Tsuchiya M, Misawa T, Seyama Y, Noshiro H, Sakamoto E, Hasegawa K, Kawabata Y, Uchida Y, Kameyama S, Ko S, Takao T, Kitahara K, Nakahira S, Baba H, Watanabe M, Yamamoto M, Nakamura M.

J Hepatobiliary Pancreat Sci. 2020 Feb;27(2):47-55. doi: 10.1002/jhbp.695. Epub 2019 Dec 11.

PMID:
31665567
3.

Cartilage repair and inhibition of the progression of cartilage degeneration after transplantation of allogeneic chondrocyte sheets in a nontraumatic early arthritis model.

Takatori N, Sato M, Toyoda E, Takahashi T, Okada E, Maehara M, Watanabe M.

Regen Ther. 2018 Aug 24;9:24-31. doi: 10.1016/j.reth.2018.07.003. eCollection 2018 Dec.

4.

Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue.

Toyoda E, Sato M, Takahashi T, Maehara M, Nakamura Y, Mitani G, Takagaki T, Hamahashi K, Watanabe M.

Regen Ther. 2018 Nov 20;10:17-26. doi: 10.1016/j.reth.2018.10.005. eCollection 2019 Jun.

5.

Intra-articular administration of EP2 enhances the articular cartilage repair in a rabbit model.

Tani Y, Sato M, Yokoyama M, Yokoyama M, Takahashi T, Toyoda E, Okada E, Fujimura S, Maruki H, Kato Y, Yamato M, Okano T, Mochida J.

J Tissue Eng Regen Med. 2018 Nov;12(11):2179-2187. doi: 10.1002/term.2748. Epub 2018 Sep 4.

PMID:
30075064
6.

Rabbit xenogeneic transplantation model for evaluating human chondrocyte sheets used in articular cartilage repair.

Takahashi T, Sato M, Toyoda E, Maehara M, Takizawa D, Maruki H, Tominaga A, Okada E, Okazaki K, Watanabe M.

J Tissue Eng Regen Med. 2018 Oct;12(10):2067-2076. doi: 10.1002/term.2741. Epub 2018 Aug 14.

7.

Quality assessment of cellular and tissue-based products using liquid chromatography-tandem mass spectrometry.

Tominaga A, Sato M, Takahashi T, Toyoda E, Toyoda K, Suzuki T, Takahashi M, Watanabe M, Okazaki K.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):429-435. doi: 10.1016/j.bbrc.2018.01.001. Epub 2018 Jan 4.

8.

Characterization of polydactyly-derived chondrocyte sheets versus adult chondrocyte sheets for articular cartilage repair.

Maehara M, Sato M, Toyoda E, Takahashi T, Okada E, Kotoku T, Watanabe M.

Inflamm Regen. 2017 Nov 1;37:22. doi: 10.1186/s41232-017-0053-6. eCollection 2017.

9.

Effects of a cell-free method using collagen vitrigel incorporating TGF-β1 on articular cartilage repair in a rabbit osteochondral defect model.

Maruki H, Sato M, Takezawa T, Tani Y, Yokoyama M, Takahashi T, Toyoda E, Okada E, Aoki S, Mochida J, Kato Y.

J Biomed Mater Res B Appl Biomater. 2017 Nov;105(8):2592-2602. doi: 10.1002/jbm.b.33792. Epub 2016 Oct 12.

PMID:
27731928
10.

Clinical research of regenerative treatment of knee cartilage using chondrocyte cell - sheet technology.

Toyoda E, Sato M, Mochida J.

Nihon Rinsho. 2015 Jun;73 Suppl 5:504-8. Japanese. No abstract available.

PMID:
30458414
11.

[A comparison of chest radiographs between patients with pulmonary Mycobacterium kansasii infection and those with Mycobacterium tuberculosis infection in the initial stage of disease].

Inoue E, Senoo M, Nagayama N, Masuda K, Matsui H, Tamura A, Nagai H, Akagawa S, Toyoda E, Oota K.

Kekkaku. 2013 Aug;88(8):619-23. Japanese.

PMID:
24044165
12.

Elucidating the mechanism by which Gypsum fibrosum, a traditional Chinese medicine, maintains cutaneous water content.

Ikarashi N, Ogiue N, Toyoda E, Nakamura M, Kon R, Kusunoki Y, Aburada T, Ishii M, Tanaka Y, Machida Y, Ochiai W, Sugiyama K.

Biol Pharm Bull. 2013;36(10):1615-21. Epub 2013 Aug 2.

13.

[Molecular heterogeneity of alpha 1-antitrypsin in the urine of the urolithiasis].

Kawakami Y, Toyoda E, Kubota R, Kanamori K, Shimomura H, Sakai N, Shiba K.

Rinsho Byori. 2013 Jan;61(1):25-31. Japanese.

PMID:
23672078
14.

Catalytic activity of Pt/TaB2(0001) for the oxygen reduction reaction.

Toyoda E, Jinnouchi R, Ohsuna T, Hatanaka T, Aizawa T, Otani S, Kido Y, Morimoto Y.

Angew Chem Int Ed Engl. 2013 Apr 8;52(15):4137-40. doi: 10.1002/anie.201209413. Epub 2013 Mar 12. No abstract available.

PMID:
23553985
15.

Gypsum fibrosum and its major component CaSO4 increase cutaneous aquaporin-3 expression levels.

Ikarashi N, Ogiue N, Toyoda E, Kon R, Ishii M, Toda T, Aburada T, Ochiai W, Sugiyama K.

J Ethnopharmacol. 2012 Jan 31;139(2):409-13. doi: 10.1016/j.jep.2011.11.025. Epub 2011 Nov 25.

PMID:
22138657
16.

[Tuberculosis in the elderly].

Toyoda E.

Nihon Ronen Igakkai Zasshi. 2010;47(6):554-7. Japanese. No abstract available.

17.

[A case of tuberculosis with multiple lung nodules, abdominal lymphadenopathy, and splenomegaly].

Horie M, Tarui M, Kashizaki F, Kawashima M, Suzuki J, Shimada M, Araki K, Komiya K, Matsui Y, Ohshima N, Masuda K, Tamura A, Nagayama N, Toyoda E, Nagai H, Akagawa S, Nakajima Y.

Kekkaku. 2009 Oct;84(10):675-9. Japanese.

PMID:
19928550
18.

Differentiation of first-episode schizophrenia patients from healthy controls using ROI-based multiple structural brain variables.

Takayanagi Y, Kawasaki Y, Nakamura K, Takahashi T, Orikabe L, Toyoda E, Mozue Y, Sato Y, Itokawa M, Yamasue H, Kasai K, Kurachi M, Okazaki Y, Matsushita M, Suzuki M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):10-7. doi: 10.1016/j.pnpbp.2009.09.004. Epub 2009 Sep 13.

PMID:
19751790
19.
20.

Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.

Toyoda E, Kurosawa A, Kamekawa H, Adachi N.

Biochem Biophys Res Commun. 2009 May 8;382(3):492-6. doi: 10.1016/j.bbrc.2009.03.047. Epub 2009 Mar 13.

PMID:
19285952
21.

[A case of primary pulmonary cryptococcosis presenting with acute respiratory failure].

Matsui Y, Akagawa S, Hebisawa A, Suzuki J, Shimada M, Kawashima M, Suzuki J, Masuda K, Matsui H, Tamura A, Nagai H, Nagayama N, Toyoda E, Machida K, Kurashima A, Yotsumoto H.

Nihon Kokyuki Gakkai Zasshi. 2008 Dec;46(12):1039-44. Japanese.

PMID:
19195208
22.

The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.

Rao VA, Klein SR, Agama KK, Toyoda E, Adachi N, Pommier Y, Shacter EB.

Cancer Res. 2009 Feb 1;69(3):948-57. doi: 10.1158/0008-5472.CAN-08-1437. Epub 2009 Jan 27.

23.

Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.

Toyoda E, Doi R, Kami K, Mori T, Ito D, Koizumi M, Kida A, Nagai K, Ito T, Masui T, Wada M, Tagawa M, Uemoto S.

Int J Oncol. 2008 Dec;33(6):1141-7.

PMID:
19020746
24.

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.

Toyoda E, Doi R, Kami K, Mori T, Ito D, Koizumi M, Kida A, Nagai K, Ito T, Masui T, Wada M, Tagawa M, Uemoto S.

J Exp Clin Cancer Res. 2008 Aug 21;27:30. doi: 10.1186/1756-9966-27-30.

25.

Evaluation of the ameliorative effects of immunosuppressants on crescentic glomerulonephritis in SCG/Kj mice.

Saiga K, Yoshida M, Nakamura I, Toyoda E, Tokunaka K, Morohashi H, Abe F, Nemoto K, Nose M.

Int Immunopharmacol. 2008 Sep;8(9):1183-9. doi: 10.1016/j.intimp.2008.04.005. Epub 2008 May 15.

PMID:
18602063
26.

NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Toyoda E, Kagaya S, Cowell IG, Kurosawa A, Kamoshita K, Nishikawa K, Iiizumi S, Koyama H, Austin CA, Adachi N.

J Biol Chem. 2008 Aug 29;283(35):23711-20. doi: 10.1074/jbc.M803936200. Epub 2008 Jul 2.

27.

[Efficacy of vitreous surgery for uveal effusion syndrome].

Ohkita T, Emi K, Toyoda E, Ueno C, Sawada K, Sawada K, Matsumura N, Morita S, Kashimoto D, Oyagi T, Ikeda T.

Nippon Ganka Gakkai Zasshi. 2008 May;112(5):472-5. Japanese.

PMID:
18517008
28.

[Evaluation of the efficacy of intravitreal gas injection for submacular hemorrhages].

Sawada K, Ikeda T, Oyagi T, Okita T, Kashimoto D, Bando H, Morita S, Matsumura N, Sawada K, Toyoda E, Ueno C, Emi K.

Nippon Ganka Gakkai Zasshi. 2008 Apr;112(4):382-8. Japanese.

PMID:
18444418
29.

[Influence of vitrectomy for diabetic retinopathy on health-related quality of life].

Emi K, Oyagi T, Ikeda T, Bando H, Okita T, Kashimoto D, Morita S, Matsumura N, Sawada K, Sawada K, Toyoda E, Ueno C.

Nippon Ganka Gakkai Zasshi. 2008 Feb;112(2):141-7. Japanese.

PMID:
18318275
30.

[Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].

Kaneko Y, Nagayama N, Kawabe Y, Shimada M, Suzuki J, Kunogi M, Matsui Y, Kawashima M, Suzuki J, Ariga H, Oshima N, Masuda K, Matsui H, Nagai H, Tamura A, Akagawa S, Toyoda E, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2008 Jan;83(1):13-9. Japanese.

PMID:
18283910
31.

[Predictive factors for treatment incompletion in elderly patients with newly diagnosed pulmonary tuberculosis].

Fuse ET, Takeda Y, Toyoda E, Mikami A, Kobayashi N, Kudo K.

Kekkaku. 2007 Nov;82(11):803-8. Japanese.

PMID:
18078105
32.

NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.

Onda T, Toyoda E, Miyazaki O, Seno C, Kagaya S, Okamoto K, Nishikawa K.

Cancer Lett. 2008 Jan 18;259(1):99-110. Epub 2007 Nov 12.

PMID:
17998154
33.

Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.

Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S.

J Surg Res. 2007 Oct;142(2):281-6. Epub 2007 Jul 19.

PMID:
17640673
34.
35.

Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.

Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R.

Surgery. 2006 Aug;140(2):149-60.

PMID:
16904964
36.

Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

Furuyama K, Doi R, Mori T, Toyoda E, Ito D, Kami K, Koizumi M, Kida A, Kawaguchi Y, Fujimoto K.

World J Surg. 2006 Feb;30(2):219-26.

PMID:
16425085
37.

In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer.

Ito D, Fujimoto K, Mori T, Kami K, Koizumi M, Toyoda E, Kawaguchi Y, Doi R.

Int J Cancer. 2006 May 1;118(9):2337-43.

38.

NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice.

Saiga K, Toyoda E, Tokunaka K, Masuda A, Matsumoto S, Mashiba H, Kuramochi H, Nemoto K, Abe F, Kawagishi N, Furukawa H, Ono M.

Bone Marrow Transplant. 2006 Feb;37(3):317-23.

PMID:
16299543
39.

Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.

Kataoka K, Fujimoto K, Ito D, Koizumi M, Toyoda E, Mori T, Kami K, Doi R.

Surgery. 2005 Sep;138(3):450-5.

PMID:
16213898
40.

Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.

Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M.

Surgery. 2005 Aug;138(2):299-305.

PMID:
16153440
41.

Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1.

Koizumi M, Doi R, Fujimoto K, Ito D, Toyoda E, Mori T, Kami K, Kawaguchi Y, Gittes GK, Imamura M.

Surgery. 2005 Aug;138(2):125-33.

PMID:
16153418
42.

Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.

Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K.

Surgery. 2005 Jul;138(1):71-7.

PMID:
16003319
43.

[Tuberculosis and human rights].

Nagai H, Inagaki T, Toyoda E, Kawabe Y, Fujiwara K, Masuyama H, Takahashi S.

Kekkaku. 2005 Jan;80(1):31-45. Japanese.

PMID:
15839061
44.

Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines.

Toyoda E, Doi R, Koizumi M, Kami K, Ito D, Mori T, Fujimoto K, Nakajima S, Wada M, Imamura M.

Pancreas. 2005 Mar;30(2):168-73.

PMID:
15714139
45.

NK95806, a newly synthesized microtubule-disrupting agent that suppresses collagen-induced arthritis in mice.

Morohashi H, Abe F, Saiga K, Toyoda E, Ichimura E, Nishikawa K.

Int Immunopharmacol. 2004 Nov;4(12):1437-43.

PMID:
15351313
46.

Hepatic regeneration and enforced PDX-1 expression accelerate transdifferentiation in liver.

Koizumi M, Doi R, Toyoda E, Tulachan SS, Kami K, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Gittes GK, Imamura M.

Surgery. 2004 Aug;136(2):449-57.

PMID:
15300214
47.

Survivin expression is a prognostic marker in pancreatic cancer patients.

Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Fujimoto K, Wada M, Miyatake S, Imamura M.

Surgery. 2004 Aug;136(2):443-8.

PMID:
15300213
48.

Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.

Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M.

Surgery. 2004 Aug;136(2):364-74.

PMID:
15300203
49.

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.

Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4125-33.

50.

Conditional transformation of mouse pancreatic epithelial cells: an in vitro model for analysis of genetic events in pancreatocarcinogenesis.

Koizumi M, Ito D, Fujimoto K, Toyoda E, Kami K, Mori T, Doi R, Whitehead R, Imamura M.

Biochem Biophys Res Commun. 2004 Jun 25;319(2):612-21.

PMID:
15178450

Supplemental Content

Loading ...
Support Center